The Role of Macrophages in the Pathogenesis of ALI/ARDS.

Huang X, Xiu H, Zhang S, Zhang G. · 2018

Read The Role of Macrophages in the Pathogenesis of ALI/ARDS. by Huang X, Xiu H, Zhang S, Zhang G. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5989173.txt.

Introduction

Huang and co-authors review the role of macrophages in acute lung injury and acute respiratory distress syndrome. Their review appeared in Mediators of Inflammation. These lung conditions kill many patients in intensive care. Their inner mechanism still needs fuller explanation. Macrophages are central to the inflammatory process here. They play a two-sided role across the illness. Setting and disease stage decide their stance.

In the acute phase they shift to the M1 state, the authors explain. They then release strong pro-inflammatory mediators. Later they swing back to M2 to clear dead cells. That later work also feeds fibrosis. Steering macrophage function may treat these syndromes.

Catalog record

CREATORHuang X, Xiu H, Zhang S, Zhang G.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5989173

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Role of Macrophages in the Pathogenesis of ALI/ARDS By Xiaofang Huang, Huiqing Xiu, Shufang Zhang, Gensheng Zhang Published in: Mediators of Inflammation DOI: 10.1155/2018/1264913 ABSTRACT Abstract Despite development in the understanding of the pathogenesis of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), the underlying mechanism still needs to be elucidated. Apart from leukocytes and endothelial cells, macrophages are also essential for the process of the inflammatory response in ALI/ARDS. Notably, macrophages play a dual role of proinflammation and anti-inflammation based on the microenvironment in different pathological stages. In the acute phase of ALI/ARDS, resident alveolar macrophages, typically expressing the alternatively activated phenotype (M2), shift into the classically activated phenotype (M1) and release various potent proinflammatory mediators. In the later phase, the M1 phenotype of activated resident and recruited macrophages shifts back to the M2 phenotype for eliminating apoptotic cells and participating in fibrosis. In this review, we summarize the main subsets of macrophages and the associated signaling pathways in three different pathological phases of ALI/ARDS. According to the current literature, regulating the function of macrophages and monocytes might be a promising therapeutic strategy against ALI/ARDS. 1. INTRODUCTION Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a devastating respiratory disorder, which leads to mortality in patients in intensive care units [1]. It is characterized by clinically significant hypoxemia, diffuse bilateral pulmonary infiltration, pulmonary edema, a decrease in pulmonary compliance, and a decrease in the functional residual capacity [2]. Pathological changes include increased vascular permeability caused by alveolar-capillary membrane dysfunction, with flooding of protein-rich fluid, alveolar hemorrhage, and fibrin deposition [3]. ALI/ARDS develops by excessive and uncontrolled systemic inflammatory responses to direct or indirect lung injury. Currently, there is increasing evidence suggesting that macrophages, including resident alveolar macrophages (AMs) and recruited macrophages from the blood, are key factors in the pathogenesis of ALI/ARDS [4, 5]. The role of macrophages during development of the inflammatory response is subtle. In general, they exert a proinflammatory effect in the early stage and exhibit an anti-inflammatory effect in the late stage. These effects may be attributed to the phenotypic transformation, which is in part regulated by the suppressor of cytokine signaling (SOCS) 1/SOCS3 and interferon regulatory factor (IRF) 4/IRF5 [6–9]. In this review, we summarize the main subsets of macrophages involved in ALI/ARDS and the recent advances in the phenotypic and functional alterations. The identification of the cellular and molecular mechanisms associated with the role of macrophages in ALI/ARDS will provide a basis for some potential treatment strategies. 2. MAIN MACROPHAGES INVOLVED IN ALI/ARDS Classified by the responses to environmental stimuli, there are two polarization states of macrophages: the classically activated phenotype (M1) and the alternatively activated phenotype (M2) [10]. There are two main types of macrophages in the alveolus. The first type is the long-lived resident AMs, which are located at the air-tissue interface, with an approximate density of seven per alveolus [11]. As a predominant cell type in the alveolar airspaces, they act as a uniform, quiescent, and immunosuppressive population in the normal state [12, 13]. The M2 phenotype is the main form of these resident AMs. The second type is the recruited AMs. When a stimulus occurs, such as in ALI/ARDS, peripheral blood monocytes are recruited into the alveolar lumen, where they differentiate into macrophages with the M1 phenotype [11, 14]. To further investigate the role of AMs in the pathogenesis of ALI/ARDS, clodronate-loaded liposomes have been used to eliminate AMs specifically in blockage experiments [15, 16]. Other studies have shown that the depletion of AMs significantly reduced pulmonary edema and ventilator-induced lung injury in rats [17, 18], which was partially attributed to the decreased recruitment of neutrophils in the lungs. Besides, depletion of AMs also has been found [19] to mitigate lung injury significantly at 4 h after lipopolysaccharide (LPS) administration in mice by attenuating neutrophilic alveolitis and reducing proinflammatory cytokines. Machado-Aranda et al. [20] have shown that neutrophils were significantly recruited to the bronchoalveolar lavage fluid from 5 h after contusion-induced lung injury in the AM-depleted group, which resulted in a worsened pulmonary compliance, an increased lung permeability, and aggressively elevated proinflammatory cytokine levels. In a study by Broug-Holub et al. [21], substantial neutrophil recruitment and decreased bacterial clearance were found in the lungs of AM-depleted mice at 48 h after infection with Klebsiella pneumoniae. In addition, Narasaraju et al. [22] have shown that influenza infection led to excessive recruitment of neutrophils, extensive alveolar damage, and increased viral load in the AM-depleted group at 5 days after infection. According to these results from various experimental models, AM depletion shows a protective effect against ALI/ARDS at an early stage, while it exacerbates lung injury at a later stage. Neutrophils are the first leukocytes recruited to the sites of inflammation in response to chemokines such as macrophage inflammatory protein-2 (MIP-2) and interleukin- (IL-) 8 released by activated AMs [23–26]. The accumulation of neutrophils is an important factor leading to tissue damage due to the overwhelming release of cytotoxic and proinflammatory mediators [27]. At an early stage, AM depletion may alleviate neutrophil-induced alveolitis by reducing inflammatory responses. At a later stage, circulating monocytes migrate into the interstitium or alveolar spaces in response to monocyte chemoattractant protein-1 (MCP-1) for pathogen clearance and phagocytosis of infected particles or other inflammatory debris (Figure 1(a)) [13, 28]. Macrophage phagocytosis of neutrophils and other apoptotic cells is an important step in the process of inflammatory response regulation. At this stage, the number of recruited AMs is increased, and the depletion of AMs may result in decreased phagocytic macrophages and control of inflammation. On the other hand, intraperitoneal administration of MCP-1 significantly increased the total number of macrophages as well as the number of phagocytizing neutrophils [29]. The increased chemokine ligand 2 (CCL-2 or MCP-1) expression in turn enhances CC chemokine receptor 2 (CCR2) expression in circulating monocytes and interstitial macrophages [30]. The interaction of CCL-2 with CCR2 plays an important role in the process of reepithelialization after lung injury [31]. In mice subjected to intratracheal LPS treatment, CCR2 deficiency aggravated the apoptosis of alveolar epithelial cells and permeability injury [32]. Therefore, these two types of AMs act at an early or a late stage in the process of ALI/ARDS: the resident AMs release cytokines for recruiting neutrophils or monocytes to promote and sustain inflammation, and the recruited AMs mainly function to clear pathogens and limit inflammatory responses. [Figure: The molecular mechanism of SOCS- and IRF-regulated cytokine signaling in macrophages during ALI/ARDS. (a) Normal resident AMs are activated and shift into the M1 phenotype upon certain stimulation during the exudative phase of ALI/ARDS. Proinflammatory cytokines such as IFN-γ, TNF-α, and IL-β are excreted by M1 macrophages into the site of inflammation. The JAK–STAT1 pathway is activated by IFN-γ, and SOCS1 and SOCS3 are induced. SOCS1 and SOCS3 inhibit the signaling pathway by different mechanisms. IRF5 promotes M1 polarization by directly binding to IL-12 and IL-23 promoters. Leukocytes migrate into the cellular airspace by the activation of chemokines such as KC, MIP-2, and IL-8. Monocytes from the circulation are also recruited by chemokines such as MCP-1 and shift into the M1 phenotype. Crosstalk between SOCS3 and IRF5 may exist. (b) Macrophages shift from the M1 phenotype to the

Read the complete text